Cargando…
Dendritic cell-targeting chemokines inhibit colorectal cancer progression
AIM: Recent progress in cancer immunotherapy has shown its promise and prompted researchers to develop novel therapeutic strategies. Dendritic cells (DCs) are professional antigen-presenting cells crucial for initiating adaptive anti-tumor immunity, therefore a promising target for cancer treatment....
Autores principales: | Yuan, Pengkun, Zhou, Yunyi, Wang, Zhixue, Gui, Liming, Ma, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Exploration
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834269/ https://www.ncbi.nlm.nih.gov/pubmed/36654820 http://dx.doi.org/10.37349/etat.2022.00115 |
Ejemplares similares
-
CCL28 Downregulation Attenuates Pancreatic Cancer Progression Through Tumor Cell-Intrinsic and -Extrinsic Mechanisms
por: Yan, Jingjing, et al.
Publicado: (2021) -
Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer
por: Zou, Qian, et al.
Publicado: (2022) -
MicroRNA-144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C-X-C motif chemokine ligand 11
por: Han, Bin, et al.
Publicado: (2018) -
Knockdown of lncRNA CCEPR suppresses colorectal cancer progression
por: Duan, Yuxia, et al.
Publicado: (2019) -
Chemokine-Targeted Mouse Models of Human Primary and Metastatic Colorectal Cancer
por: Chen, Huanhuan Joyce, et al.
Publicado: (2015)